RE:RE:RE:RE:RE:ANDA - 505(b)(2) Actually, litigation is only ongoing with one corp, the other 12 have settled with Jazz gaining marketing/selling approval on the condition of certain, unknown to the public milestones...and yes epidiolex is only CBD, however instead of 100$ a bottle it's 1700-2200$ covered by insurers....so very significant margins to be had....pharma is the diamond jubilee and labs will be partaking no doubt for me...